DEF 14A

Company

Moleculin Biotech, Inc.

Filed

April 27, 2018

Period of Report

April 27, 2018

Accession Number

0001659617-18-000046

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →